CP-T2 30mg

Description

CP-T2 30mg is supplied as lyophilized powder with a labeled amount of 30mg per vial for in-vitro laboratory research.

Product specifications

• Product: CP-T2 30mg
• Label amount: 30mg per vial
• Form: lyophilized powder
• Intended use: in-vitro laboratory research only

Current batch and COA

BT Labs report COA261200-002 documents batch CP-TZ30-0608. The sample was tested August 28, 2026; the report is dated September 2, 2026.

• Identity: batch-specific FTIR identification is documented in the laboratory report, which also notes excipients/fillers.
• HPLC purity: 99.8%
• HPLC potency: 33.1mg

The product has a 30mg label amount; 33.1mg is the laboratory’s measured result for the submitted sample. These findings apply to the tested sample and do not establish identical results for every vial or future batch.

Read the CP-TZ30-0608 COA summary (page 1 of 2). Match your product’s lot number to its documentation; the ChoicePeps batch ledger provides a reference for listed lots.

CP-T2 research information and other amounts

For educational context, see the CP-T2 research overview. Research background does not establish clinical benefits from a ChoicePeps vial.

Other product options include CP-T2 10mg, CP-T2 40mg and CP-T2 60mg. Each page provides its own label amount and batch documentation.

For laboratory research only. Not for human or veterinary use, diagnosis or treatment. Read the research-use-only information.